
Journal of Medicinal Chemistry p. 4384 - 4392 (1992)
Update date:2022-08-02
Topics:
Harris, Neil V.
Smith, Christopher
Asthon, Michael J.
Bridge, Andrew W.
Bush, Raymond C.
et al.
A potent, bioavailable ACAT inhibitor may have beneficial effects in the treatment of atherosclerosis by (i) reducing the absorption of dietary cholesterol, (ii) reducing the secretion of very low density lipoproteins into plasma from the liver, and (iii) preventing the transformation of arterial macrophages into foam cells.We have found that a mevalonate derivative 2, which contains a 4,5-diphenyl-1H-imidazol-2-yl moiety, inhibits rat hepatic microsomal ACAT in vitro and produces a significant hypocholesterolemic effect in the cholesterol-fed rat.Structure-activity relationships for analogues of 2 demonstrate that the 4,5-diphenyl-1H-imidazole moiety is a pharmacophore for inhibition of rat microsomal ACAT.
View MoreChemsky(shanghai)International Co.,Ltd.
Contact:0
Address:0
website:http://www.chinabarton.com
Contact:+86-573-82719618
Address:No. 162 Fumin Road, Honghe Town,
Zouping Mingxing Chemical Co.,Ltd.
website:http://www.zoutong.com.cn
Contact:86-543-2240068 2240067
Address:428 Daixi Third Road Zouping County Shandong Province China
Shenzhen HwaGen Pharmaceutical Co., Ltd
website:http://www.rafflespt.com
Contact:+86-752-5538396
Address:Guangdong Huizhou China
Longhui qunfeng Chemical Co., Ltd
Contact:86-731-82173407
Address:South-east Industrial Park, Longhui County, Hunan Province, China
Doi:10.1007/BF00503478
(1981)Doi:10.1039/c39850000190
(1985)Doi:10.1021/je00042a047
(1985)Doi:10.1016/S0040-4039(00)98119-X
(1985)Doi:10.1021/jacs.5b07438
(2015)Doi:10.1021/jm00149a029
(1985)